Dayton Therapeutics
Dayton Therapeutics is a clinical oncology company focused on identifying and developing compounds for new cancer indications with limited therapeutic options. The company leverages proprietary oncologist expertise combined with AI and data mining to systematically identify high-potential candidates for cancer treatments addressing large unmet medical needs. Their Onco-indication engine, proven effective with two compounds, is being scaled to maximize drug development utility and provide a risk-mitigated pipeline of future oncology drug launches. Based in Switzerland, Dayton Therapeutics aims to innovate by adapting existing drugs for new oncology indications, enhancing therapeutic options for patients.
Dayton Therapeutics
Dayton Therapeutics is a clinical oncology company focused on identifying and developing compounds for new cancer indications with limited therapeutic options. The company leverages proprietary oncologist expertise combined with AI and data mining to systematically identify high-potential candidates for cancer treatments addressing large unmet medical needs. Their Onco-indication engine, proven effective with two compounds, is being scaled to maximize drug development utility and provide a risk-mitigated pipeline of future oncology drug launches. Based in Switzerland, Dayton Therapeutics aims to innovate by adapting existing drugs for new oncology indications, enhancing therapeutic options for patients.